Exosomes from Schwann cells may help improve nerve function in diabetic mice
Schwann cell derived exosomes improve diabetic peripheral neuropathy in type II diabetic mice
This study is looking at how tiny particles from special cells can help improve nerve health in mice with diabetic nerve damage, and it hopes to show that these particles can make nerves work better without changing blood sugar levels.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health System NIH-funded |
| Lab location | 1 site (Detroit, United States) |
| Project ID | NIH-10643939 on NIH RePORTER |
What this research studies
This research investigates how exosomes derived from Schwann cells can enhance nerve function in mice with diabetic peripheral neuropathy (DPN), a common complication of diabetes. The study focuses on the communication between Schwann cells and nerve cells, utilizing exosomes to transfer beneficial molecules that may restore nerve health. By administering these exosomes to diabetic mice, researchers aim to observe improvements in nerve structure and function without significantly altering blood glucose levels.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type II diabetes who are experiencing symptoms of peripheral neuropathy.
Not a fit: Patients without diabetes or those with other forms of neuropathy unrelated to diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve nerve function and reduce pain for patients suffering from diabetic peripheral neuropathy.
How similar studies have performed: Other research has shown promising results using exosomes for nerve repair, suggesting that this approach may be effective in treating diabetic peripheral neuropathy.
Where this research is happening
Detroit, United States
- Henry Ford Health System — Detroit, United States (Active)
Researchers
- Principal investigator: Wang, Lei — Henry Ford Health System
- Study coordinator: Wang, Lei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.